Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Frei

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|January 1, 1986
A specific immune response to purified HA antigen (HAAg) demonstrated by leukocyte migration inhibition in patients recovering from viral hepatitis AJ Fasel-Folley, L R Overby, P C Frei
Journal of Hepatology|September 1, 1992
Monitoring of interferon-alpha treatment in chronic active hepatitis BD Lavanchy, C Mayerat, P C Frei, et al.
Lancet (London, England)|October 17, 1987
Routine tests for HIV antigenR Peitrequin, I Graf, J P Lantin, et al.
Archives of Dermatological Research|January 1, 1983
Chemotaxis: basic aspects of methodology, mechanisms and pathologyB M Czarnetzki, E Kownatzki, M Dierich, et al.
International Journal of Immunopharmacology|January 1, 1985
Influence of palmitoyl-3-catechin and heptyl-3-catechin on the leucocyte migration inhibition test carried out in the presence of PPD and hepatitis B surface antigen (HBsAg)A Nicole, J Fasel-Felley, D Perrissoud, et al.
Revue Medicale De La Suisse Romande|May 1, 1992
[Seroprevalence of cytomegalovirus infections in patients on hemodialysis, renal allograft recipients and the general population of French-speaking Switzerland]P Lopez-Mata, D Lavanchy, J P Wauters, et al.
Journal of Clinical Microbiology|November 1, 1996
Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitationC Mayerat, P Bürgisser, D Lavanchy, et al.
Medical Microbiology and Immunology|June 5, 2001
Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune responseG Greub, F Zysset, B Genton, et al.
Bulletin of the World Health Organization|December 29, 1999
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the SeychellesP Bovet, C Yersin, P Herminie, et al.
Research in Virology|September 1, 1991
Anti-pre-S2 antibody response in subjects vaccinated against hepatitis B and in naturally immunized subjectsD Lavanchy, B Fritzell, B Geudelin, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|January 1, 1986
A specific immune response to purified HA antigen (HAAg) demonstrated by leukocyte migration inhibition in patients recovering from viral hepatitis AJ Fasel-Folley, L R Overby, P C Frei
Journal of Hepatology|September 1, 1992
Monitoring of interferon-alpha treatment in chronic active hepatitis BD Lavanchy, C Mayerat, P C Frei, et al.
Lancet (London, England)|October 17, 1987
Routine tests for HIV antigenR Peitrequin, I Graf, J P Lantin, et al.
Archives of Dermatological Research|January 1, 1983
Chemotaxis: basic aspects of methodology, mechanisms and pathologyB M Czarnetzki, E Kownatzki, M Dierich, et al.
International Journal of Immunopharmacology|January 1, 1985
Influence of palmitoyl-3-catechin and heptyl-3-catechin on the leucocyte migration inhibition test carried out in the presence of PPD and hepatitis B surface antigen (HBsAg)A Nicole, J Fasel-Felley, D Perrissoud, et al.
Revue Medicale De La Suisse Romande|May 1, 1992
[Seroprevalence of cytomegalovirus infections in patients on hemodialysis, renal allograft recipients and the general population of French-speaking Switzerland]P Lopez-Mata, D Lavanchy, J P Wauters, et al.
Journal of Clinical Microbiology|November 1, 1996
Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitationC Mayerat, P Bürgisser, D Lavanchy, et al.
Medical Microbiology and Immunology|June 5, 2001
Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune responseG Greub, F Zysset, B Genton, et al.
Bulletin of the World Health Organization|December 29, 1999
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the SeychellesP Bovet, C Yersin, P Herminie, et al.
Research in Virology|September 1, 1991
Anti-pre-S2 antibody response in subjects vaccinated against hepatitis B and in naturally immunized subjectsD Lavanchy, B Fritzell, B Geudelin, et al.
Pageof 12